Silverstein Foundation Announces Grant Funding to AcureX Therapeutics. 2021.08.31-Silverstein-Foundation-AcureX-Therapeutics-PRDownload
Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001